USPTO serial 79239994
LIPISPERSE
Reviewed by CopyMark Law Group
Reg. 5772190Status 739Registered
- Filing date
- Status date
- Registration date
- Jun 11, 2019
- Examiner
- VAGHANI, MAYUR C
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with LIPISPERSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Pharmako Biotechnologies Pty Limited
Frenchs Forest, AU
Other trademarks owned by Pharmako Biotechnologies Pty Limited
Pharmako Biotechnologies Pty Limited
CROMER NSW 2099, AU
Other trademarks owned by Pharmako Biotechnologies Pty Limited
Pharmako Biotechnologies Pty Limited
CROMER NSW 2099, AU
Other trademarks owned by Pharmako Biotechnologies Pty Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stephen Drysdale
908/233 Pyrmont StreetPyrmont, 2009AUSTRALIAGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Dietetic food preparations adapted for medical purposes, nutritional food additives for medical use or for use as dietary supplement with medicinal properties in the nature of lipid based excipients, namely, crystalline lipophilic substances that increase the oral bioavailability and absorption of the crystalline lipophilic active ingredients of food stuff, food additive or dietary supplement with medicinal properties, comprising powdered preparations, tablets and capsules | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Pharmako Biotechnologies Pty Limited
- Other trademarks owned by Pharmako Biotechnologies Pty Limited
- Other trademarks owned by Pharmako Biotechnologies Pty Limited
- Other trademarks in Class 005
- Similar marks named LIPISPERSE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 10, 2025 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Sep 10, 2025 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Sep 8, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 9, 2025 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Jun 11, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 17, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 8, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 25, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 12, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 23, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 23, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 11, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 11, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 19, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 11, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 26, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 26, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 6, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 6, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 6, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 15, 2019 | ALIE | ASSIGNED TO LIE | — |
| Feb 5, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 16, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 16, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 16, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 21, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 13, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 24, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 24, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 18, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 18, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 17, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 12, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 12, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 6, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |